Atnaujinkite slapukų nuostatas

El. knyga: Future of Medical Device Regulation: Innovation and Protection

Edited by (University of Copenhagen), Edited by (Harvard Law School, Massachusetts), Edited by (University of Michigan, Ann Arbor), Edited by (Harvard Law School, Massachusetts), Edited by (Boston University)
  • Formatas: PDF+DRM
  • Išleidimo metai: 07-Apr-2022
  • Leidėjas: Cambridge University Press
  • Kalba: eng
  • ISBN-13: 9781108982047
  • Formatas: PDF+DRM
  • Išleidimo metai: 07-Apr-2022
  • Leidėjas: Cambridge University Press
  • Kalba: eng
  • ISBN-13: 9781108982047

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Regulators have been more permissive for medical devices compared to their drug and biologic counterparts. While innovative products can thereby reach consumers more quickly, this approach raises serious public health and safety concerns. Additionally, the nature of medical devices is rapidly changing, as software has become as important as hardware. Regulation must keep pace with the current developments and controversies of this technology. This volume provides a multidisciplinary evaluation of the ethical, legal, and regulatory concerns surrounding medical devices in the US and EU. For medical providers, policymakers, and other stakeholders, the book offers a framework for the opportunities and challenges on the horizon for medical device regulation. Readers will gain a nuanced overview of the latest developments in patient privacy and safety, innovation, and new regulatory laws. This book is also available as Open Access on Cambridge Core.

As the nature of medical devices is rapidly changing, the legal and ethical questions around medical devices are becoming ever more complex. This volume analyses the current issues and controversies around patient privacy, innovation, and new regulatory laws in the US and EU.

Daugiau informacijos

A detailed analysis of the ethical, legal, and regulatory landscape of medical devices in the US and EU.
List of Figures
x
List of Tables
xi
List of Contributors
xii
Acknowledgments xiv
Introduction 1(10)
I. Glenn Cohen
Timo Minssen
W. Nicholson Price
Christopher Robertson
Carmel Shachar
PART I AI AND DATA AS MEDICAL DEVICES
Introduction
11(2)
W. Nicholson Price
1 Lifecycle Regulation and Evaluation of Artificial Intelligence and Machine Learning-Based Medical Devices
13(9)
Kerstin N. Vokinger
Thomas J. Hwang
Aaron S. Kesselheim
2 Product Liability Suits for FDA-Regulated AI/ML Software
22(14)
Barbara J. Evans
Frank Pasquale
3 Are Electronic Health Records Medical Devices?
36(11)
Craig Konnoth
PART II EUROPEAN REGULATION OF MEDICAL DEVICES
Introduction
47(4)
Timo Minssen
4 Cybersecurity of Medical Devices: Regulatory Challenges in the European Union
51(12)
Elisabetta Biasin
Erik Kamenjasevic
5 The mHealth Power Paradox: Improving Data Protection in Health Apps through Self-Regulation in the European Union
63(14)
Hannah van Kolfschooten
6 The Interaction of the Medical Device Regulation and the GDPR: Do European Rules on Privacy and Scientific Research Impair the Safety and Performance of AI Medical Devices?
77(14)
Janos Meszaros
Marcelo Corrales Compagnucci
Timo Minssen
7 AI, Explainability, and Safeguarding Patient Safety in Europe: Toward a Science-Focused Regulatory Model
91(12)
Barry Solaiman
Mark C. Bloom
8 Regulation of Digital Health Technologies in the European Union: Intended versus Actual Use
103(12)
Helen Yu
PART III DESIGNING MEDICAL DEVICE REGULATIONS
Introduction
115(2)
I. Glenn Cohen
9 IP and FDA Regulation of De Novo Medical Devices
117(12)
Mateo Aboy
Jacob S. Sherkow
10 A "DESI" for Devices? Can a Pharmaceutical Program from the 1960s Improve FDA Oversight of Medical Devices?
129(12)
Matthew Herder
Nathan Cortez
11 Digital Home Health During the COVID-19 Pandemic: Challenges to Safety, Liability, and Informed Consent, and the Way to Move Forward
141(20)
Sara Gerke
PART IV THE IMPACT OF MEDICAL DEVICE REGULATION ON PATIENTS AND MARKETS
Introduction
161(4)
Christopher Robertson
12 Clouded Judgment: Preventing Conflicts of Interest in Drug Courts
165(14)
Jody Lynee Madeira
Barbara Andraka-Christou
Lori Ann Eldridge
Ross D. Silverman
13 Disrupting the Market for Ineffective Medical Devices
179(13)
Wendy Netter Epstein
14 Preventing Medical Device-Borne Outbreaks: The Case of High-Level Disinfection Policy for Duodenoscopes
192(11)
Preeti Mehrotra
David J. Weber
Ameet Sarpahvari
15 Regulating Devices that Create Life
203(12)
Katherine L. Kraschel
PART V MEDICAL AND LEGAL OVERSIGHT OF MEDICAL DEVICES
Introduction
215(2)
Carmel Shachar
16 Ensuring Patient Safety and Benefit in Use of Medical Devices Granted Expedited Approval
217(12)
Sanket S. Dhruva
Jonathan J. Darrow
Aaron S. Kesselheim
Rita F. Redberg
17 Compulsory Medical Device Registries: Legal and Regulatory Issues
229(15)
Efthimios Parasidis
Daniel B. Kramer
18 Professional Self-Regulation in Medicine: Will the Rise of Intelligent Tools Mean the End of Peer Review?
244(12)
Anthony P. Weiss
Barak D. Richman
19 Regulating Posttrial Access to In-Dwelling Class III Neural Devices
256(12)
Megan S. Wright
Joseph J. Fins
20 Strengthening the Power of Health Care Insurers to Regulate Medical Device Risks
268
David Rosenberg
Adeyemi Adediran
I. Glenn Cohen is James A. Attwood and Leslie Williams Professor of Law, Deputy Dean, and Faculty Director in the Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics, Harvard Law School. Timo Minssen is Professor of Law is Director of the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) in the Faculty of Law, University of Copenhagen, Denmark. W. Nicholson Price II is Professor of Law in the University of Michigan School of Law. Christopher Robertson is Professor and N. Neal Pike Scholar of Health and Disability Law in the School of Law, Boston University. Carmel Shachar is Executive Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.